DAY ONE BIOPHARMACEUTICALS INC. - COMMON STOCK

Day One to Participate in the Piper Sandler 35th Annual Healthcare Conference

14 11月 2023 05:00:00 条件 Nasdaq GlobeNewswire

Day One Reports Third Quarter 2023 Financial Results and Corporate Progress

06 11月 2023 13:30:05 条件 Nasdaq GlobeNewswire

Day One Announces FDA Acceptance of NDA and Priority Review for Tovorafenib in Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)

30 10月 2023 05:00:00 条件 Nasdaq GlobeNewswire

Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)

11 9月 2023 05:30:00 条件 Nasdaq GlobeNewswire

Day One Announces VRK1 License Agreement and Research Collaboration with Sprint Bioscience

16 8月 2023 05:00:00 条件 Nasdaq GlobeNewswire

Day One Reports Second Quarter 2023 Financial Results and Corporate Progress

07 8月 2023 13:30:00 条件 Nasdaq GlobeNewswire

Day One Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

12 6月 2023 05:00:01 条件 Nasdaq GlobeNewswire

Day One Announces Pricing of Public Offering of Common Stock

06 6月 2023 19:31:14 条件 Nasdaq GlobeNewswire

Day One Announces Proposed Public Offering of Common Stock

06 6月 2023 13:01:00 条件 Nasdaq GlobeNewswire

Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101) and Initiation of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma

04 6月 2023 09:45:00 条件 Nasdaq GlobeNewswire

Day One to Participate in the Goldman Sachs 44th Annual Healthcare Conference

30 5月 2023 05:00:00 条件 Nasdaq GlobeNewswire

CORRECTION -- Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

25 5月 2023 17:30:53 条件 Nasdaq GlobeNewswire

Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

25 5月 2023 14:00:00 条件 Nasdaq GlobeNewswire

Day One Reports First Quarter 2023 Financial Results and Corporate Progress

01 5月 2023 06:00:00 条件 Nasdaq GlobeNewswire

Day One Announces Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

26 4月 2023 06:31:48 条件 Nasdaq GlobeNewswire

Day One Announces Upcoming Presentation at 19th European Association of Dermato-Oncology (EADO) Congress

12 4月 2023 05:00:38 条件 Nasdaq GlobeNewswire

Day One Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Progress

06 3月 2023 13:30:00 条件 Nasdaq GlobeNewswire

Day One to Participate in the Cowen 43rd Annual Health Care Conference

27 2月 2023 05:00:02 条件 Nasdaq GlobeNewswire

Day One Announces Topline Data from Pivotal Phase 2 FIREFLY-1 Trial Demonstrating Meaningful Responses with Tovorafenib (DAY101) in Recurrent or Progressive Pediatric Low-Grade Glioma

08 1月 2023 14:00:00 条件 Nasdaq GlobeNewswire

Day One to Present at the 41st Annual J.P. Morgan Healthcare Conference

20 12月 2022 05:00:00 条件 Nasdaq GlobeNewswire